This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Modernatx, Inc., Ares Capital Corporation, as Agent. Active years: 2023-2026.
Company Filing History:
Years Active: 2023-2026
Title: The Innovative Contributions of Mike Smith
Introduction
Mike Smith is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of lipid nanoparticles, with a focus on methods that enhance the delivery of therapeutics. With a total of 3 patents, his work is paving the way for advancements in medical technology.
Latest Patents
Mike Smith's latest patents include innovative methods of producing nucleic acid lipid nanoparticle (LNP) compositions. These methods employ a modifying agent after the formation of a precursor nucleic acid lipid nanoparticle. The produced compositions are useful in delivering therapeutics and prophylactics, such as nucleic acids, to mammalian cells or organs. This technology aims to regulate polypeptide, protein, or gene expression, showcasing the potential impact of his inventions on healthcare.
Career Highlights
Mike Smith is currently associated with Modernatx, Inc., where he continues to develop groundbreaking technologies. His expertise in lipid nanoparticles has positioned him as a key player in the field of biotechnology. His contributions are not only advancing scientific knowledge but also enhancing therapeutic applications.
Collaborations
Mike collaborates with talented individuals such as Joseph Schariter and Kimberly Hassett. Their combined efforts contribute to the innovative environment at Modernatx, Inc., fostering creativity and progress in their projects.
Conclusion
In summary, Mike Smith's work in lipid nanoparticles represents a significant advancement in the delivery of therapeutics. His patents and collaborations highlight his commitment to innovation in the field of biotechnology.